ProHealth fibromyalgia Resource
 SUBSCRIBE TO OUR FREE E-NEWSLETTERS  
Click Here to Preview
Log In
Catalog Quick Order
Your Account
Shopping Cart
 Check Out
ProHealth: News, Research, Vitamins & Supplements About ProHealth ProHealth ImmuneSupport.com ProHealth Online Vitamin & Supplement Store ProHealth Treatment & Research Library ProHealth Community ProHealth Vitamins & Supplements Catalog
Your Purchase Helps Fund Health Research

Fibromyalgia

Home
Fibromyalgia 101
Symptom
Treatment
Library
RSS Subscribe to RSS
Celebrating 20 Years
Explore Our Health Sites
ProHealth Vitamin and Supplement Catalog
ProHealth Health & Wellness Research & News Catalog
Your Purchases Help Fund Ongoing Research
 
 
Search our extensive library for information, solutions & support
Site
Message Board  
Abstracts
Newsletters  
Articles
Products  

Allodynia in migraine: Association with comorbid pain conditions – Source: Headache, Oct 2009

by GE Tietjen, et al.
October 1, 2009

[Note: Cutaneous allodynia, commonly associated with migraine, is pain resulting from normally non-painful stimulus to skin or scalp.]

Background: Cutaneous allodynia (CA) in migraine is a clinical manifestation of central nervous system sensitization. Several chronic pain syndromes and mood disorders are comorbid with migraine.
 
In this study we examine the relationship of migraine-associated CA with these comorbid conditions. We also evaluate the association of CA with factors such as demographic profiles, migraine characteristics, and smoking status that may have an influence on the relationships of CA to pain and mood.

Methods:
Data are from a cross-sectional multicenter study of comorbid conditions in persons seeking treatment in headache clinics.

Diagnosis of migraine was determined by a physician based on the International Classification of Headache Disorders-II criteria.

Participants completed a self-administered questionnaire ascertaining sociodemographics, migraine-associated allodynia, physician-diagnosed comorbid medical and psychiatric disorders, headache-related disability, current depression, and anxiety.

Results:
A total of 1,413 migraineurs (mean age = 42 years, 89% women) from 11 different headache treatment centers completed a survey on the prevalence of comorbid conditions.

Aura was reported by 38% and chronic headache by 35% of the participants.

Sixty percent of the study population reported at least one migraine-related allodynic symptom, 10% reported 4 or more symptoms.

Symptoms of cutaneous allodynia were associated with female gender, body mass index, current smoking, presence of aura, chronic headaches, transformed headaches, severe headache-related disability, and duration of migraine illness from onset.

The prevalence of self-reported physician diagnosis of:

• Comorbid pain conditions (irritable bowel syndrome, chronic fatigue syndrome, fibromyalgia)

• And psychiatric conditions (current depression and anxiety)

…was also associated with symptoms of cutaneous allodynia.

Adjusted ordinal regression indicated a significant association between number of pain conditions and severity of cutaneous allodynia (based on symptom count).

Adjusting for sociodemographics, migraine characteristics, and current depression and anxiety, the likelihood of reporting symptoms of severe allodynia was much higher in those with:

• 3 or more pain conditions (odds ratio = 3.03, 95% confidence interval: 1.78-5.17),

• And 2 pain conditions (odds ratio = 2.67, 95% confidence interval: 1.78-4.01)

…when compared with those with no comorbid pain condition.

[Note: an odds ratio of 1.0 would denote no difference in odds of allodynia between migraine patients with pain conditions & those without. So the OR of 3.03 indicates 203% greater likelihood of allodynia with all three pain conditions, and the OR of 2.67 indicates 167% greater odds with two pain conditions.]

Conclusion:
Symptoms of cutaneous allodynia in migraine were associated with current anxiety, depression, and several chronic pain conditions.

A graded relationship was observed between number of allodynic symptoms and the number of pain conditions, even after adjusting for confounding factors.

This study also presents the novel association of cutaneous allodynia symptoms with younger age of migraine onset, and with cigarette smoking, in addition to confirming several previously reported findings.

Source: Headache, Oct 2009;49(9):1333-44. PMID: 19788473, by Tietjen GE, Brandes JL, Peterlin BL, Eloff A, Dafer RM, Stein MR, Drexler E, Martin VT, Hutchinson S, Aurora SK, Recober A, Herial NA, Utley C, White L, Khuder SA. The University of Toledo College of Medicine, Toledo, Ohio, USA.



DISCUSS THIS ARTICLE   (0 existing comments) Post a Comment 
fibromyalgia Research Articles



[ Be the first to comment on this article ]




Allodynia in migraine: Association with comorbid pain conditions – Source: Headache, Oct 2009 Article Tools
Print Page Print Page Email Article Email Article
Discuss Discuss
  Rate This
Featured Vitamins, Supplements, and Health Products
Cuddle Ewe™ Underquilt Slip Cover Cuddle Ewe™ Underquilt Slip Cover
100% Cotton fabric
CF Support-p CF Support-p
Growth factors support healthy adrenal function for more energy
Acetyl L-Carnitine + Alpha Lipoic Acid Acetyl L-Carnitine + Alpha Lipoic Acid
Supports healthy brain activity
ProEnzyme™ P ProEnzyme™ P
Complete enzymatic formula supports joints
Glucosamine, MSM & Arnica Lotion by Now Foods Glucosamine, MSM & Arnica Lotion by Now Foods
Helps relieve aches & pains
Most Viewed Articles & Abstracts
Dr. Mikovits Presentation Jan 22 on XMRV at ProHealth.com [more]

VIDEOS of Dr. Mikovits XMRV Seminar and Q&A [more]

Why ME/CFS may kill you: Disorders in the inflammatory and oxidative and nitrosative stress (IO&NS) ... [more]

Coenzyme Q10 - The Energy Maker [more]

Recall of OTC ‘Staples’ Tylenol, Motrin, Rolaids, St. Joseph Aspirin, More [more]

ProHealth Vitamin and Supplement SmartSavings Club
Security Enabled AlertSite is a leading provider of Web site monitoring and performance management solutions that help businesses ensure optimum Web experiences for their customers. TrustE Better Business Bureau BizRate Customer Certified (GOLD) Site

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
ADVANCED MEDICAL LABS   |   WHOLESALE   |   AFFILIATES   |   CONTACT US   |   PRIVACY   |   GLOSSARY   |   CUSTOMER SERVICE   |   RELATED SITES   |   RSS
Email us or Call toll-free 800-366-6056 · Monday through Friday, 7 a.m.-5 p.m. Pacific Time
International Callers dial 001.805.564.3064
Copyright © 2010 ProHealth, Inc.